Get started
Source

Drug Discovery Today TARGETS

ISSNs: 1741-8372, 1878-7363
Source type: journal
Publisher: Elsevier BV
Alternate name: DDT. Targets
Fully OA: No
DOAJ: No
OpenAlex ID: S155923265
Zebrafish as a model system for drug target screening and validation
2004 · Saulius Sumanas, Shuo Lin · Drug Discovery Today TARGETS · 41
Functional pharmacology: the drug discovery bottleneck?
2004 · Michael J.A. Walker, Terrance Barrett, et al. · Drug Discovery Today TARGETS · 31
Moonlighting proteins: complications and implications for proteomics research
2004 · Constance J. Jeffery · Drug Discovery Today TARGETS · 31
Microarray technology: an increasing variety of screening tools for proteomic research
2004 · Dieter Stoll, Jutta Bachmann, et al. · Drug Discovery Today TARGETS · 31
Modeling drug action in the mouse with knockouts and RNA interference
2004 · Brian P. Zambrowicz, Arthur T. Sands · Drug Discovery Today TARGETS · 26
Carbohydrate arrays as tools for the glycomics revolution
2004 · Matthew D Disney, Peter H Seeberger · Drug Discovery Today TARGETS · 26
Factors that contribute to the complexity of protein digests
2004 · Éva Hunyadi-Gulyás, Katalin F. Medzihradszky · Drug Discovery Today TARGETS · 15
COFRADIC™: the Hubble telescope of proteomics
2004 · Kris Gevaert, Joël Vandekerckhove · Drug Discovery Today TARGETS · 15
Intensity-fading MALDI-TOF-MS: novel screening for ligand binding and drug discovery
2004 · Óscar Yanes, Josep Villanueva, et al. · Drug Discovery Today TARGETS · 13
In silico predictions of target clinical efficacy
2004 · Christina M. Friedrich, Thomas S. Paterson · Drug Discovery Today TARGETS · 12
High-throughput technologies for studying potassium channels – progresses and challenges
2004 · Jia Xu, Ying Chen, et al. · Drug Discovery Today TARGETS · 12
Ribozymes in gene identification, target validation and drug discovery
2004 · Jon E. Chatterton, Xiuyuan Hu, et al. · Drug Discovery Today TARGETS · 12
Tethering in early target assessment
2004 · Johan D Oslob, Daniel A Erlanson · Drug Discovery Today TARGETS · 11
Fold recognition for drug discovery
2004 · Kenji Mizuguchi · Drug Discovery Today TARGETS · 11
Quantitative proteomics by metabolic labeling with stable isotopes
2004 · Jeroen Krijgsveld, Albert J.R. Heck · Drug Discovery Today TARGETS · 9
Biomedical marker molecules for cancer – current status and perspectives
2004 · Oliver Stoss, Thomas Henkel · Drug Discovery Today TARGETS · 7
Minimum information about a functional genomics experiment: the state of microarray standards and their extension to other technologies
2004 · Christian J Stoeckert, John Quackenbush, et al. · Drug Discovery Today TARGETS · 7
The targetable G protein proteome: where is the next generation of drug targets?
2004 · R.Victor Rebois, Bruce G. Allen, et al. · Drug Discovery Today TARGETS · 7
Target discovery using the yeast two-hybrid system
2004 · Robert Hollingsworth, Julia H. White · Drug Discovery Today TARGETS · 7
Functional protein microarrays for pathway mapping
2004 · Gregory A. Michaud, Rhonda Bangham, et al. · Drug Discovery Today TARGETS · 6
High-throughput target validation in model organisms
2004 · Thanh N. Doan, Carmen D. Eilertson, et al. · Drug Discovery Today TARGETS · 6
Are drugs discovered in the clinic or the laboratory?
2004 · Andrew Hopkins · Drug Discovery Today TARGETS · 6
Target identification and validation through genetics
2004 · Maxine J. Allen, Alisoun H. Carey · Drug Discovery Today TARGETS · 6
Whole genome variation analysis using single molecule sequencing
2004 · Tony Smith · Drug Discovery Today TARGETS · 6
Mass spectrometry has married statistics: uncle is functionality, children are selectivity and sensitivity
2004 · Jacques Colinge, Alexandre Masselot · Drug Discovery Today TARGETS · 5
Works count: 70
Citation count: 397
H-index: 12
I10-index: 14
2yr mean citedness:
Year
Topic
Type